V
Power Law company profile
Vitrolife
Biotech & Life Sciences · Göteborgs Stad, Sweden · Founded 1994 · IPO 2002 Unicorn
Valuation
$1.79B
Market cap · Apr/2026
Revenue
$416M
Latest reported FY
Global footprint
Where Vitrolife has talent and traffic
AI talent share
1.8%
of workforce is AI talent
(6 of 333 staff)
(6 of 333 staff)
Core AI41.2%
Other AI20.6%
Non-AI workforce32798.2%
Patent intelligence
$21M patent portfolio · 17 active families
Total estimated portfolio value via Dealroom Patent Intelligence (Patsnap), with quality scores compared against same-sector peers.
Estimated portfolio value
$21M
1.2% of market cap · 12.1× smaller than top peer Zealand Pharma ($254M)
17 active patent families
Where Vitrolife innovates
Culture mediumsCellIn vitroEmbryoBiotechnology
Below peer median on Legal, Strategic, Market, Economic, Technology
Quality vs same-sector peers
Vitrolife on the five Patsnap quality dimensions
Vitrolife in orange. Same-sector peers are the top filers by total patent value. All scores 0–100; higher is stronger.
Compare against
Patent quality scores (0–100)
Source: Dealroom Patent Intelligence · PatsnapTech-focus vs peers
Where Vitrolife concentrates inside the peer cluster
Axes are the most-shared Patsnap topics across Vitrolife and its top peers. Each polygon's reach on an axis = how prominent that topic is in that company's portfolio (#1 topic = 100, #10 = 10, absent = 0).
Compare against
Top-topic prominence (rank inverted, 0–100)
Source: Dealroom Patent Intelligence · Patsnap top-10 topics per companySee Vitrolife on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.